Cargando…
Hormone Resistance in Two MCF-7 Breast Cancer Cell Lines is Associated with Reduced mTOR Signaling, Decreased Glycolysis, and Increased Sensitivity to Cytotoxic Drugs
The mTOR pathway is a key regulator of multiple cellular signaling pathways and is a potential target for therapy. We have previously developed two hormone-resistant sub-lines of the MCF-7 human breast cancer line, designated TamC3 and TamR3, which were characterized by reduced mTOR signaling, reduc...
Autores principales: | Leung, Euphemia Yee, Kim, Ji Eun, Askarian-Amiri, Marjan, Joseph, Wayne R., McKeage, Mark J., Baguley, Bruce C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4153047/ https://www.ncbi.nlm.nih.gov/pubmed/25232533 http://dx.doi.org/10.3389/fonc.2014.00221 |
Ejemplares similares
-
Potentiation of Growth Inhibitory Responses of the mTOR Inhibitor Everolimus by Dual mTORC1/2 Inhibitors in Cultured Breast Cancer Cell Lines
por: Leung, Euphemia Y., et al.
Publicado: (2015) -
Evidence for the Existence of Triple-Negative Variants in the MCF-7 Breast Cancer Cell Population
por: Leung, Euphemia, et al.
Publicado: (2014) -
Keeping abreast with long non-coding RNAs in mammary gland development and breast cancer
por: Hansji, Herah, et al.
Publicado: (2014) -
Epigenetic regulation in human melanoma: past and future
por: Sarkar, Debina, et al.
Publicado: (2015) -
Endocrine Therapy of Estrogen Receptor-Positive Breast Cancer Cells: Early Differential Effects on Stem Cell Markers
por: Leung, Euphemia Y., et al.
Publicado: (2017)